Harmony Biosciences Holdings, Inc. - Rasio total nilai perusahaan marang pendapatan HRMY

Logo perusahaan publik harmonybiosciences.com (HRMY)

Harmony Biosciences revenues rely on insurance reimbursements for the treatment of rare nervous system disorders. The Enterprise Value to Sales ratio on GURU.Markets reflects the current scaling potential, where the value 1413.83 serves as the baseline indicator. The business's non-cyclical resilience is ensured by the demand for therapy, while absolute pricing power is secured by the unique drug Wakix for the treatment of sleepiness.

Harmony Biosciences (HRMY): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Harmony Corp - rincian analitis lan metrik utama (HRMY)

- rega saham lan prakiraan rega para ahli:
- informasi babagan dhuwit lan arus kas:
Pambiji fundamental perusahaan:HRMY, harmonybiosciences.com
Produk asil prodhuksi Harmony Pharma

The market values Harmony Biosciences (HRMY) through the lens of its ability to monetize unique developments. This indicator compares the total enterprise value with annual revenue, excluding the impact of debt load. By analyzing the EV/Sales valuation multiple, an investor determines the price of one dollar of revenue. For Harmony Biosciences (HRMY), a high valuation is justified by patent protection and the exclusive status of orphan drugs. This confirms the resilience of the business model in the face of regulatory barriers.

Analisis pesaing

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|BHVN: Rasio nilai perusahaan marang pendapatan|AMLX: Multiplikator EV/Sales|TRVI: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Praxis Medicines|Multiplikator nilai perusahaan marang pendapatan Anavex AVXL|Rasio nilai perusahaan marang pendapatan CeriBell Corp (CBLL)|Koefisien nilai perusahaan marang pendapatan PRTA|Multiplikator EV/Sales ALEC (Alector)|Annexon (ANNX) - Multiplikator nilai perusahaan marang pendapatan|OMER - Rasio nilai perusahaan marang pendapatan|NGNE (Neurogene) - Rasio nilai perusahaan marang pendapatan|ACIU: Multiplikator EV/Sales|VYGR - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Neumora Therapeutics, Inc.|Rasio nilai perusahaan marang pendapatan SCLX (Scilex)|Nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Multiplikator EV/Sales Alpha Cognition Inc (ACOG)|Multiplikator EV/Sales CGTX (cogrx.com)|Rasio total nilai perusahaan marang pendapatan Inhibikase Pharma (IKT)|SAVA: Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Assertio ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan VTGN|OVID (Ovid Therapeutics) - Multiplikator EV/Sales|Acumen Pharmaceuticals, Inc (ABOS) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan CervoMed, Inc. (CRVO)|ATHE - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales CLNN (Clene Inc.)|Rasio total nilai perusahaan marang pendapatan PepGen Inc. (PEPG)|JUNS - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Relmada Corp|ANVS (Annovis Bio, Inc.) - Nilai perusahaan marang pendapatan|Grace Tx (GRCE) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AIFF|Multiplikator EV/Sales anewmeds.com|Rasio nilai perusahaan marang pendapatan NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Nilai bisnis marang pendapatan|MetaVia - Nilai perusahaan marang pendapatan|NRXS: Rasio nilai perusahaan marang pendapatan|Helius Medical Technologies, Inc. - Multiplikator EV/Sales|PASG: Rasio nilai perusahaan marang pendapatan|Neuphoria (NEUP) - Rasio nilai perusahaan marang pendapatan|Minerva Neurosciences - Nilai bisnis marang pendapatan|ATHA (Athira Pharma, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan addextherapeutics.com ADXN|Nilai perusahaan marang pendapatan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PTIX (Protagenic)|Multiplikator EV/Sales pasitheaclinics.com KTTA|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE